Laurence I. Wu - Concepedia

Author

Laurence I. Wu

Procter & Gamble (United States)

Also Known As

Laurence I. Wu

Publications

386

Citations

H-Index

Concepts

All Affiliations

Procter & Gamble (United States)Bristol-Myers Squibb (United States)

About

Laurence I. Wu is an author at Procter & Gamble (United States) specializing in medicinal chemistry, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	153
2	Natural Sciences	3	3	131
3	Biochemistry	3	3	131
4	Engineering	1	1	87
5	Health Sciences	1	1	12

Laurence I. Wu

Publications

383

Citations

H-Index

Page 1

	Year	Citations
Discovery and Preclinical Studies of (<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5- methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor Rajeev S. Bhide, Zhen‐Wei Cai, Yong‐Zheng Zhang, Journal of Medicinal Chemistry	2006	131
Enantioselective total synthesis of miroestrol E. J. Corey, Laurence I. Wu Journal of the American Chemical Society AltmetricsEnantioselective SynthesisEngineeringInformation RetrievalAltmetric Attention Score	1993	87
New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 1. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Discovery and Variation of the 5-Keto Substituent John M. Janusz, Patricia A. Young, James M. Ridgeway, Journal of Medicinal Chemistry PharmacotherapyNew Cyclooxygenase-2/5-lipoxygenase InhibitorsPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry	1998	53
New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations at the 5 Position John M. Janusz, Patricia A. Young, James M. Ridgeway, Journal of Medicinal Chemistry Bioorganic ChemistryGastrointestinal PharmacologyDual CyclooxygenasePharmacotherapyNew Cyclooxygenase-2/5-lipoxygenase Inhibitors	1998	44
New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 2. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations of the Dihydrobenzofuran Ring John M. Janusz, Patricia A. Young, Michael W. Scherz, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyHeterocycle ChemistryNew Cyclooxygenase-2/5-lipoxygenase InhibitorsPharmaceutical Chemistry	1998	34
Design, synthesis, and structure–activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors Louis J. Lombardo, Amy Camuso, John K. Clark, Bioorganic & Medicinal Chemistry Letters Tetrahydroquinoline-based Farnesyltransferase InhibitorsMedicinal ChemistryMedicinePharmacologyPharmaceutical Chemistry	2005	22
Preference for photodissociation over internal [2 + 2]-cycloaddition during irradiation of an unsaturated α,β-enone E. J. Corey, Laurence I. Wu Tetrahedron Letters PhotochemistryMechanistic PhotochemistryChemistryRadiation ChemistryPhotosynthesis	1994	12

Page 1